PharmatrophiX and Circular Genomics have partnered to advance blood-based circular RNA biomarkers in neurodegenerative drug development programmes. This collaboration aims to enhance the understanding and treatment of neurodegenerative diseases through innovative biomarker research.
The partnership may provide new insights into the mechanisms of these diseases, potentially leading to more effective therapeutic strategies. For manufacturers and suppliers in the biotech sector, this collaboration highlights the growing importance of biomarker-driven approaches in drug development, which could influence future research and investment priorities.
Source: pharmaceutical-technology.com · Image: NIH- Unidentified Laboratory Photos (CC0)
Explore deeper: the API & FDF Intelligence database is more than a directory.
It combines global coverage of APIs, excipients, and finished dosage forms with real market intelligence.
You’ll find:
– Price ranges for APIs, excipients, and formulations.
– DMF, CEP, and GMP compliance status.
– Manufacturer portfolios by product and geography.
– Direct contacts for every producer and FDF holder, ready for outreach.
Instead of scattered spreadsheets and endless searches, the entire picture is a few clicks away. Subscription starts at an accessible rate — see how much time and budget you save by centralizing everything.
Start your 7-day trial and see what the database can do →
Start your 7-day trial and see what the database can do →
